ReP USP - Resultado da busca

Artigo de periodico
Clinicopathological characteristics and recurrence risk in patients with ductal carcinoma in situ of the breast (2023)
Bruno, Marcelo Hueb Cecilio Naves; Souza, Vitor Hugo de; Orlandini, Leonardo Fleury ; Carrara, Helio Humberto Angotti ; Reis, Francisco José Candido dos ; Andrade, Jurandyr Moreira de ; Bosquesi, Priscila Longhin; Tiezzi, Daniel Guimarães
Source: Mastology. Unidade: FMRP
Subjects: CARCINOMA, PROGNÓSTICO, MAMA, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRUNO, Marcelo Hueb Cecilio Naves et al. Clinicopathological characteristics and recurrence risk in patients with ductal carcinoma in situ of the breast. Mastology, v. 33, p. 1-6, 2023Tradução . . Disponível em: https://doi.org/10.29289/259453942023006. Acesso em: 14 jul. 2025.
APA
Bruno, M. H. C. N., Souza, V. H. de, Orlandini, L. F., Carrara, H. H. A., Reis, F. J. C. dos, Andrade, J. M. de, et al. (2023). Clinicopathological characteristics and recurrence risk in patients with ductal carcinoma in situ of the breast. Mastology, 33, 1-6. doi:10.29289/259453942023006
NLM
Bruno MHCN, Souza VH de, Orlandini LF, Carrara HHA, Reis FJC dos, Andrade JM de, Bosquesi PL, Tiezzi DG. Clinicopathological characteristics and recurrence risk in patients with ductal carcinoma in situ of the breast [Internet]. Mastology. 2023 ; 33 1-6.[citado 2025 jul. 14 ] Available from: https://doi.org/10.29289/259453942023006
Vancouver
Bruno MHCN, Souza VH de, Orlandini LF, Carrara HHA, Reis FJC dos, Andrade JM de, Bosquesi PL, Tiezzi DG. Clinicopathological characteristics and recurrence risk in patients with ductal carcinoma in situ of the breast [Internet]. Mastology. 2023 ; 33 1-6.[citado 2025 jul. 14 ] Available from: https://doi.org/10.29289/259453942023006
Artigo de periodico
10-year opportunistic mammographic screening scenario in Brazil and its impact on breast cancer early detection: a nationwide population-based study (2022)
Cuoghi, Isabela Campeti; Soares, Mariana Furlani da Silva; Santos, Gustavo Motta Cabello dos; Reis, Francisco José Candido dos ; Poli Netto, Omero Benedicto ; Andrade, Jurandyr Moreira de ; Bosquesi, Priscila Longhin; Orlandini, Leonardo Fleury ; Tiezzi, Daniel Guimarães
Source: Journal of Global Health. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, DIAGNÓSTICO POR IMAGEM, ESTUDOS TRANSVERSAIS, DIAGNÓSTICO PRECOCE, MAMOGRAFIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUOGHI, Isabela Campeti et al. 10-year opportunistic mammographic screening scenario in Brazil and its impact on breast cancer early detection: a nationwide population-based study. Journal of Global Health, v. 12, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.7189/jogh.12.04061. Acesso em: 14 jul. 2025.
APA
Cuoghi, I. C., Soares, M. F. da S., Santos, G. M. C. dos, Reis, F. J. C. dos, Poli Netto, O. B., Andrade, J. M. de, et al. (2022). 10-year opportunistic mammographic screening scenario in Brazil and its impact on breast cancer early detection: a nationwide population-based study. Journal of Global Health, 12, 1-9. doi:10.7189/jogh.12.04061
NLM
Cuoghi IC, Soares MF da S, Santos GMC dos, Reis FJC dos, Poli Netto OB, Andrade JM de, Bosquesi PL, Orlandini LF, Tiezzi DG. 10-year opportunistic mammographic screening scenario in Brazil and its impact on breast cancer early detection: a nationwide population-based study [Internet]. Journal of Global Health. 2022 ; 12 1-9.[citado 2025 jul. 14 ] Available from: https://doi.org/10.7189/jogh.12.04061
Vancouver
Cuoghi IC, Soares MF da S, Santos GMC dos, Reis FJC dos, Poli Netto OB, Andrade JM de, Bosquesi PL, Orlandini LF, Tiezzi DG. 10-year opportunistic mammographic screening scenario in Brazil and its impact on breast cancer early detection: a nationwide population-based study [Internet]. Journal of Global Health. 2022 ; 12 1-9.[citado 2025 jul. 14 ] Available from: https://doi.org/10.7189/jogh.12.04061
Artigo de periodico
Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil (2022)
Magario, Marcos Benini; Santos, Raquel Rocha dos ; Teixeira, Lorena Alves ; Tiezzi, Daniel Guimarães ; Pimentel, Franklin Fernandes ; Carrara, Helio Humberto Angotti ; Andrade, Jurandyr Moreira de ; Reis, Francisco José Candido dos
Source: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, PROGNÓSTICO, SOBREVIDA, VALIDAÇÃO DE MODELOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAGARIO, Marcos Benini et al. Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil. Brazilian Journal of Medical and Biological Research, v. 55, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.1590/1414-431X2022e12109. Acesso em: 14 jul. 2025.
APA
Magario, M. B., Santos, R. R. dos, Teixeira, L. A., Tiezzi, D. G., Pimentel, F. F., Carrara, H. H. A., et al. (2022). Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil. Brazilian Journal of Medical and Biological Research, 55, 1-8. doi:10.1590/1414-431X2022e12109
NLM
Magario MB, Santos RR dos, Teixeira LA, Tiezzi DG, Pimentel FF, Carrara HHA, Andrade JM de, Reis FJC dos. Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil [Internet]. Brazilian Journal of Medical and Biological Research. 2022 ; 55 1-8.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1590/1414-431X2022e12109
Vancouver
Magario MB, Santos RR dos, Teixeira LA, Tiezzi DG, Pimentel FF, Carrara HHA, Andrade JM de, Reis FJC dos. Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil [Internet]. Brazilian Journal of Medical and Biological Research. 2022 ; 55 1-8.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1590/1414-431X2022e12109
Artigo de periodico
Epidemiological analyses reveal a high incidence of breast cancer in young women in Brazil (2021)
Orlandini, Leonardo Fleury ; Antonio, Maria Vitoria do Nascimento; Espreafico Junior, Claiver Renato; Bosquesi, Priscila Longhin; Poli Netto, Omero Benedicto; Andrade, Jurandyr Moreira de ; Reis, Francisco José Cândido dos; Tiezzi, Daniel Guimarães
Source: JCO Global Oncology. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, ANÁLISE DE DADOS, EPIDEMIOLOGIA, ESTUDOS RETROSPECTIVOS, MEIA IDADE, INCIDÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ORLANDINI, Leonardo Fleury et al. Epidemiological analyses reveal a high incidence of breast cancer in young women in Brazil. JCO Global Oncology, v. 7, p. 81-88, 2021Tradução . . Disponível em: https://doi.org/10.1200/GO.20.00440. Acesso em: 14 jul. 2025.
APA
Orlandini, L. F., Antonio, M. V. do N., Espreafico Junior, C. R., Bosquesi, P. L., Poli Netto, O. B., Andrade, J. M. de, et al. (2021). Epidemiological analyses reveal a high incidence of breast cancer in young women in Brazil. JCO Global Oncology, 7, 81-88. doi:10.1200/GO.20.00440
NLM
Orlandini LF, Antonio MV do N, Espreafico Junior CR, Bosquesi PL, Poli Netto OB, Andrade JM de, Reis FJC dos, Tiezzi DG. Epidemiological analyses reveal a high incidence of breast cancer in young women in Brazil [Internet]. JCO Global Oncology. 2021 ; 7 81-88.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1200/GO.20.00440
Vancouver
Orlandini LF, Antonio MV do N, Espreafico Junior CR, Bosquesi PL, Poli Netto OB, Andrade JM de, Reis FJC dos, Tiezzi DG. Epidemiological analyses reveal a high incidence of breast cancer in young women in Brazil [Internet]. JCO Global Oncology. 2021 ; 7 81-88.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1200/GO.20.00440
Trabalho de evento-resumo periodico
Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system (2021)
Pimentel, Franklin Fernandes; Buzatto, Isabela Panzeri Carlotti; Rodrigues, Tamara Cristina Gomes Ferraz; Borba, Jéssica Maria Camargo; Peruchi, Karoline P. I.; Andrade, Jurandyr Moreira de ; Tiezzi, Daniel Guimarães
Source: Cancer Research. Conference titles: San Antonio Breast Cancer Virtual Symposium. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, NEOPLASIAS MAMÁRIAS, MENOPAUSA, SISTEMA ÚNICO DE SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, Franklin Fernandes et al. Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.SABCS20-PS9-27. Acesso em: 14 jul. 2025. , 2021
APA
Pimentel, F. F., Buzatto, I. P. C., Rodrigues, T. C. G. F., Borba, J. M. C., Peruchi, K. P. I., Andrade, J. M. de, & Tiezzi, D. G. (2021). Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.SABCS20-PS9-27
NLM
Pimentel FF, Buzatto IPC, Rodrigues TCGF, Borba JMC, Peruchi KPI, Andrade JM de, Tiezzi DG. Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2025 jul. 14 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS9-27
Vancouver
Pimentel FF, Buzatto IPC, Rodrigues TCGF, Borba JMC, Peruchi KPI, Andrade JM de, Tiezzi DG. Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2025 jul. 14 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS9-27
Artigo de periodico
A propensity score-matched case-control study of laparoscopy and laparotomy for endometrial cancer (2021)
Miguel, Licério; Rosa e Silva, Júlio César ; Poli Netto, Omero Benedicto; Tiezzi, Daniel Guimarães ; Andrade, Jurandyr Moreira de ; Reis, Francisco José Candido dos
Source: Revista da Associação Médica Brasileira. Unidade: FMRP
Subjects: CARCINOMA, ENDOMÉTRIO, LAPAROSCOPIA, LAPAROTOMIA, SOBREVIVÊNCIA LIVRE DE DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIGUEL, Licério et al. A propensity score-matched case-control study of laparoscopy and laparotomy for endometrial cancer. Revista da Associação Médica Brasileira, v. 67, n. 5, p. 753-758, 2021Tradução . . Disponível em: https://doi.org/10.1590/1806-9282.20210194. Acesso em: 14 jul. 2025.
APA
Miguel, L., Rosa e Silva, J. C., Poli Netto, O. B., Tiezzi, D. G., Andrade, J. M. de, & Reis, F. J. C. dos. (2021). A propensity score-matched case-control study of laparoscopy and laparotomy for endometrial cancer. Revista da Associação Médica Brasileira, 67( 5), 753-758. doi:10.1590/1806-9282.20210194
NLM
Miguel L, Rosa e Silva JC, Poli Netto OB, Tiezzi DG, Andrade JM de, Reis FJC dos. A propensity score-matched case-control study of laparoscopy and laparotomy for endometrial cancer [Internet]. Revista da Associação Médica Brasileira. 2021 ; 67( 5): 753-758.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1590/1806-9282.20210194
Vancouver
Miguel L, Rosa e Silva JC, Poli Netto OB, Tiezzi DG, Andrade JM de, Reis FJC dos. A propensity score-matched case-control study of laparoscopy and laparotomy for endometrial cancer [Internet]. Revista da Associação Médica Brasileira. 2021 ; 67( 5): 753-758.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1590/1806-9282.20210194
Artigo de periodico
Axillary ultrasound and fine-needle aspiration cytology to predict clinically relevant nodal burden in breast cancer patients (2021)
Buzatto, Isabela Panzeri Carlotti ; Reis, Francisco José Candido dos ; Andrade, Jurandyr Moreira de ; Rodrigues, Tamara Cristina Gomes Ferraz; Borba, Jéssica Maria Camargo; Netto, Amanda Homse; Polydoro, Marina Sconzo; Tiezzi, Daniel Guimarães
Source: World Journal of Surgical Oncology. Unidade: FMRP
Subjects: BIÓPSIA POR AGULHA FINA, NEOPLASIAS MAMÁRIAS, DIAGNÓSTICO POR IMAGEM, LINFONODOS, METÁSTASE LINFÁTICA, SENSIBILIDADE E ESPECIFICIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUZATTO, Isabela Panzeri Carlotti et al. Axillary ultrasound and fine-needle aspiration cytology to predict clinically relevant nodal burden in breast cancer patients. World Journal of Surgical Oncology, v. 19, p. 1-8, 2021Tradução . . Disponível em: https://doi.org/10.1186/s12957-021-02391-3. Acesso em: 14 jul. 2025.
APA
Buzatto, I. P. C., Reis, F. J. C. dos, Andrade, J. M. de, Rodrigues, T. C. G. F., Borba, J. M. C., Netto, A. H., et al. (2021). Axillary ultrasound and fine-needle aspiration cytology to predict clinically relevant nodal burden in breast cancer patients. World Journal of Surgical Oncology, 19, 1-8. doi:10.1186/s12957-021-02391-3
NLM
Buzatto IPC, Reis FJC dos, Andrade JM de, Rodrigues TCGF, Borba JMC, Netto AH, Polydoro MS, Tiezzi DG. Axillary ultrasound and fine-needle aspiration cytology to predict clinically relevant nodal burden in breast cancer patients [Internet]. World Journal of Surgical Oncology. 2021 ; 19 1-8.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1186/s12957-021-02391-3
Vancouver
Buzatto IPC, Reis FJC dos, Andrade JM de, Rodrigues TCGF, Borba JMC, Netto AH, Polydoro MS, Tiezzi DG. Axillary ultrasound and fine-needle aspiration cytology to predict clinically relevant nodal burden in breast cancer patients [Internet]. World Journal of Surgical Oncology. 2021 ; 19 1-8.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1186/s12957-021-02391-3
Artigo de periodico
Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients (2021)
Orlandini, Leonardo Fleury ; Pimentel, F. F.; Andrade, Jurandyr Moreira de ; Reis, Francisco José Candido dos; Mattos-Arruda, L. de; Tiezzi, Daniel Guimarães
Source: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, OBESIDADE, PROGNÓSTICO, SOBREVIVÊNCIA LIVRE DE DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ORLANDINI, Leonardo Fleury et al. Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients. Brazilian Journal of Medical and Biological Research, v. 54, n. 10, 2021Tradução . . Disponível em: https://doi.org/10.1590/1414-431X2021e11409. Acesso em: 14 jul. 2025.
APA
Orlandini, L. F., Pimentel, F. F., Andrade, J. M. de, Reis, F. J. C. dos, Mattos-Arruda, L. de, & Tiezzi, D. G. (2021). Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients. Brazilian Journal of Medical and Biological Research, 54( 10). doi:10.1590/1414-431X2021e11409
NLM
Orlandini LF, Pimentel FF, Andrade JM de, Reis FJC dos, Mattos-Arruda L de, Tiezzi DG. Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients [Internet]. Brazilian Journal of Medical and Biological Research. 2021 ; 54( 10):[citado 2025 jul. 14 ] Available from: https://doi.org/10.1590/1414-431X2021e11409
Vancouver
Orlandini LF, Pimentel FF, Andrade JM de, Reis FJC dos, Mattos-Arruda L de, Tiezzi DG. Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients [Internet]. Brazilian Journal of Medical and Biological Research. 2021 ; 54( 10):[citado 2025 jul. 14 ] Available from: https://doi.org/10.1590/1414-431X2021e11409
Trabalho de evento-resumo periodico
Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic (2021)
Pimentel, Franklin Fernandes; Borba, Jéssica Maria Camargo; Rodrigues, Tamara Cristina Gomes Ferraz; Peruchi, Karoline P. I.; Carrara, Helio Humberto Angotti ; Andrade, Jurandyr Moreira de ; Reis, Francisco José Candido dos
Source: Cancer Research. Conference titles: San Antonio Breast Cancer Virtual Symposium. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, TERAPÊUTICA MÉDICA, COVID-19, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, Franklin Fernandes et al. Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.SABCS20-PS13-30. Acesso em: 14 jul. 2025. , 2021
APA
Pimentel, F. F., Borba, J. M. C., Rodrigues, T. C. G. F., Peruchi, K. P. I., Carrara, H. H. A., Andrade, J. M. de, & Reis, F. J. C. dos. (2021). Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.SABCS20-PS13-30
NLM
Pimentel FF, Borba JMC, Rodrigues TCGF, Peruchi KPI, Carrara HHA, Andrade JM de, Reis FJC dos. Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2025 jul. 14 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS13-30
Vancouver
Pimentel FF, Borba JMC, Rodrigues TCGF, Peruchi KPI, Carrara HHA, Andrade JM de, Reis FJC dos. Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2025 jul. 14 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS13-30
Artigo de periodico
Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio (2020)
Pippa, Leandro Francisco ; Oliveira, Milena Locci de ; Rocha, Adriana; Andrade, Jurandyr Moreira de ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: ANTINEOPLÁSICOS, FARMACOCINÉTICA, VARIAÇÃO (BIOLOGIA), NEOPLASIAS MAMÁRIAS, MIOCARDIOPATIA CONGESTIVA, QUIMIOTERAPIA, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIPPA, Leandro Francisco et al. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio. Journal of Pharmaceutical and Biomedical Analysis, v. 185, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2020.113231. Acesso em: 14 jul. 2025.
APA
Pippa, L. F., Oliveira, M. L. de, Rocha, A., Andrade, J. M. de, & Lanchote, V. L. (2020). Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio. Journal of Pharmaceutical and Biomedical Analysis, 185. doi:10.1016/j.jpba.2020.113231
NLM
Pippa LF, Oliveira ML de, Rocha A, Andrade JM de, Lanchote VL. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 185[citado 2025 jul. 14 ] Available from: https://doi.org/10.1016/j.jpba.2020.113231
Vancouver
Pippa LF, Oliveira ML de, Rocha A, Andrade JM de, Lanchote VL. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 185[citado 2025 jul. 14 ] Available from: https://doi.org/10.1016/j.jpba.2020.113231
Artigo de periodico
Analysis of the relationship between hospital characteristics and survival in ovarian cancer: A historical cohort (2020)
Moterani, Vinicius Cesar; Tiezzi, Daniel Guimarães ; Andrade, Jurandyr Moreira de ; Reis, Francisco José Cândido dos
Source: Journal of Surgical Oncology. Unidade: FMRP
Subjects: HOSPITAIS, NEOPLASIAS OVARIANAS, CIRURGIA, ADENOCARCINOMA, MORTALIDADE, ESTUDOS RETROSPECTIVOS, TAXA DE SOBREVIVÊNCIA, ESTATÍSTICAS DE SAÚDE, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOTERANI, Vinicius Cesar et al. Analysis of the relationship between hospital characteristics and survival in ovarian cancer: A historical cohort. Journal of Surgical Oncology, v. 122, n. 8, p. 1802-1807, 2020Tradução . . Disponível em: https://doi.org/10.1002/jso.26186. Acesso em: 14 jul. 2025.
APA
Moterani, V. C., Tiezzi, D. G., Andrade, J. M. de, & Reis, F. J. C. dos. (2020). Analysis of the relationship between hospital characteristics and survival in ovarian cancer: A historical cohort. Journal of Surgical Oncology, 122( 8), 1802-1807. doi:10.1002/jso.26186
NLM
Moterani VC, Tiezzi DG, Andrade JM de, Reis FJC dos. Analysis of the relationship between hospital characteristics and survival in ovarian cancer: A historical cohort [Internet]. Journal of Surgical Oncology. 2020 ; 122( 8): 1802-1807.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1002/jso.26186
Vancouver
Moterani VC, Tiezzi DG, Andrade JM de, Reis FJC dos. Analysis of the relationship between hospital characteristics and survival in ovarian cancer: A historical cohort [Internet]. Journal of Surgical Oncology. 2020 ; 122( 8): 1802-1807.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1002/jso.26186
Artigo de periodico
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study (2020)
Swain, Sandra M.; Miles, David; Kim, Sung Bae; Im, Young-Hyuck; Im, Seock-Ah; Semiglazov, Vladimir; Ciruelos, Eva M.; Schneeweiss, Andreas; Loi, Sherene; Monturus, Estefanía; Clark, Emma; Knott, Adam; Restuccia, Eleonora; Benyunes, Mark C.; Cortés, Javier; Andrade, Jurandyr Moreira de
Source: The Lancet Oncology. Unidade: FMRP
Subjects: ANTICORPOS MONOCLONAIS, PROTOCOLOS CLÍNICOS, QUIMIOTERAPIA COMBINADA, ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS, MÉTODO DUPLO-CEGO, METÁSTASE NEOPLÁSICA, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SWAIN, Sandra M. et al. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. The Lancet Oncology, v. 21, n. 4, p. 519-530, 2020Tradução . . Disponível em: https://doi.org/10.1016/S1470-2045(19)30863-0. Acesso em: 14 jul. 2025.
APA
Swain, S. M., Miles, D., Kim, S. B., Im, Y. -H., Im, S. -A., Semiglazov, V., et al. (2020). Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. The Lancet Oncology, 21( 4), 519-530. doi:10.1016/S1470-2045(19)30863-0
NLM
Swain SM, Miles D, Kim SB, Im Y-H, Im S-A, Semiglazov V, Ciruelos EM, Schneeweiss A, Loi S, Monturus E, Clark E, Knott A, Restuccia E, Benyunes MC, Cortés J, Andrade JM de. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study [Internet]. The Lancet Oncology. 2020 ; 21( 4): 519-530.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1016/S1470-2045(19)30863-0
Vancouver
Swain SM, Miles D, Kim SB, Im Y-H, Im S-A, Semiglazov V, Ciruelos EM, Schneeweiss A, Loi S, Monturus E, Clark E, Knott A, Restuccia E, Benyunes MC, Cortés J, Andrade JM de. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study [Internet]. The Lancet Oncology. 2020 ; 21( 4): 519-530.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1016/S1470-2045(19)30863-0
Artigo de periodico
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium (2020)
Martins, Filipe Correia; Couturier, Dominique-Laurent; Paterson, Anna; Karnezis, Anthony N.; Chow, Christine; Nazeran, Tayyebeh M.; Odunsi, Adekunle; Sousa, Christiani B. de; Tiezzi, Daniel Guimarães ; Andrade, Jurandyr Moreira de ; Reis, Francisco José Candido dos
Source: British Journal of Cancer. Unidade: FMRP
Subjects: ADENOCARCINOMA, MORTALIDADE, BIOMARCADORES, NEOPLASIAS OVARIANAS, GENÉTICA, ESTUDOS DE COORTES, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, Filipe Correia et al. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium. British Journal of Cancer, v. 123, p. 793-802, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41416-020-0900-0. Acesso em: 14 jul. 2025.
APA
Martins, F. C., Couturier, D. -L., Paterson, A., Karnezis, A. N., Chow, C., Nazeran, T. M., et al. (2020). Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium. British Journal of Cancer, 123, 793-802. doi:10.1038/s41416-020-0900-0
NLM
Martins FC, Couturier D-L, Paterson A, Karnezis AN, Chow C, Nazeran TM, Odunsi A, Sousa CB de, Tiezzi DG, Andrade JM de, Reis FJC dos. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium [Internet]. British Journal of Cancer. 2020 ; 123 793-802.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1038/s41416-020-0900-0
Vancouver
Martins FC, Couturier D-L, Paterson A, Karnezis AN, Chow C, Nazeran TM, Odunsi A, Sousa CB de, Tiezzi DG, Andrade JM de, Reis FJC dos. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium [Internet]. British Journal of Cancer. 2020 ; 123 793-802.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1038/s41416-020-0900-0
Trabalho de evento-anais periodico
Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients (2019)
Ximenez, João Paulo Bianchi ; Andrade, Jurandyr Moreira de ; Marques, Maria Paula ; Coelho, Eduardo Barbosa ; Suarez-Kurtz, Guilherme ; Lanchote, Vera Lucia
Source: BMC Pharmacology and Toxicology. Conference titles: Latin American Congress of Clinical and Laboratorial Toxicology - ToxiLatin. Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS MAMÁRIAS, RECEPTORES DE DROGA, QUIMIOTERAPIA, ESTRÓGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
XIMENEZ, João Paulo Bianchi et al. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients. BMC Pharmacology and Toxicology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s40360-019-0358-y. Acesso em: 14 jul. 2025. , 2019
APA
Ximenez, J. P. B., Andrade, J. M. de, Marques, M. P., Coelho, E. B., Suarez-Kurtz, G., & Lanchote, V. L. (2019). Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients. BMC Pharmacology and Toxicology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1186/s40360-019-0358-y
NLM
Ximenez JPB, Andrade JM de, Marques MP, Coelho EB, Suarez-Kurtz G, Lanchote VL. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients [Internet]. BMC Pharmacology and Toxicology. 2019 ; 20 [10] .[citado 2025 jul. 14 ] Available from: https://doi.org/10.1186/s40360-019-0358-y
Vancouver
Ximenez JPB, Andrade JM de, Marques MP, Coelho EB, Suarez-Kurtz G, Lanchote VL. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients [Internet]. BMC Pharmacology and Toxicology. 2019 ; 20 [10] .[citado 2025 jul. 14 ] Available from: https://doi.org/10.1186/s40360-019-0358-y
Artigo de periodico-carta/editorial
Current breast cancer screening scenario in Brazil. [Editorial] (2019)
Tiezzi, Daniel Guimarães ; Orlandini, Leonardo Fleury ; Carrara, Helio Humberto Angotti ; Reis, Francisco José Candido dos ; Andrade, Jurandyr Moreira de
Source: Revista Brasileira de Ginecologia e Obstetrícia. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, ESTATÍSTICAS DE SAÚDE, INCIDÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TIEZZI, Daniel Guimarães et al. Current breast cancer screening scenario in Brazil. [Editorial]. Revista Brasileira de Ginecologia e Obstetrícia. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1055/s-0039-3399550. Acesso em: 14 jul. 2025. , 2019
APA
Tiezzi, D. G., Orlandini, L. F., Carrara, H. H. A., Reis, F. J. C. dos, & Andrade, J. M. de. (2019). Current breast cancer screening scenario in Brazil. [Editorial]. Revista Brasileira de Ginecologia e Obstetrícia. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1055/s-0039-3399550
NLM
Tiezzi DG, Orlandini LF, Carrara HHA, Reis FJC dos, Andrade JM de. Current breast cancer screening scenario in Brazil. [Editorial] [Internet]. Revista Brasileira de Ginecologia e Obstetrícia. 2019 ; 41( 11): 633-635.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1055/s-0039-3399550
Vancouver
Tiezzi DG, Orlandini LF, Carrara HHA, Reis FJC dos, Andrade JM de. Current breast cancer screening scenario in Brazil. [Editorial] [Internet]. Revista Brasileira de Ginecologia e Obstetrícia. 2019 ; 41( 11): 633-635.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1055/s-0039-3399550
Artigo de periodico
Weight gain during systemic oncologic therapy for breast cancer: changes in food intake and physical activity (2019)
Sousa, Marco Aurélio da Silva Ribeiro ; Mastelaro, Isabelle; Peria, Fernanda Maris ; Carrara, Helio Humberto Angotti ; Andrade, Jurandyr Moreira de ; Cunha, Selma Freire de Carvalho da
Source: Revista Brasileira de Cancerologia. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, GANHO DE PESO, INGESTÃO, ALIMENTOS, EXERCÍCIO FÍSICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, Marco Aurélio da Silva Ribeiro et al. Weight gain during systemic oncologic therapy for breast cancer: changes in food intake and physical activity. Revista Brasileira de Cancerologia, v. 65, n. 2, 2019Tradução . . Disponível em: https://doi.org/10.32635/2176-9745.RBC.2019v65n2.360. Acesso em: 14 jul. 2025.
APA
Sousa, M. A. da S. R., Mastelaro, I., Peria, F. M., Carrara, H. H. A., Andrade, J. M. de, & Cunha, S. F. de C. da. (2019). Weight gain during systemic oncologic therapy for breast cancer: changes in food intake and physical activity. Revista Brasileira de Cancerologia, 65( 2). doi:10.32635/2176-9745.RBC.2019v65n2.360
NLM
Sousa MA da SR, Mastelaro I, Peria FM, Carrara HHA, Andrade JM de, Cunha SF de C da. Weight gain during systemic oncologic therapy for breast cancer: changes in food intake and physical activity [Internet]. Revista Brasileira de Cancerologia. 2019 ; 65( 2):[citado 2025 jul. 14 ] Available from: https://doi.org/10.32635/2176-9745.RBC.2019v65n2.360
Vancouver
Sousa MA da SR, Mastelaro I, Peria FM, Carrara HHA, Andrade JM de, Cunha SF de C da. Weight gain during systemic oncologic therapy for breast cancer: changes in food intake and physical activity [Internet]. Revista Brasileira de Cancerologia. 2019 ; 65( 2):[citado 2025 jul. 14 ] Available from: https://doi.org/10.32635/2176-9745.RBC.2019v65n2.360
Artigo de periodico
Prognostic factors for response to chemotherapy in advanced tumors of the uterine cervix: the role of neoangiogenesis (2019)
Kfouri, Cláudio Franco do Amaral; Lombardi, Welington; Romania, Maria Clara Ferreira Nonato; Puls, Matheus Lopes; Ferreira, Rodrigo Amaral Martins; Lombardi, Luciana Borges; Andrade, Jurandyr Moreira de
Source: Revista do Colégio Brasileiro de Cirurgiões. Unidade: FMRP
Subjects: NEOPLASIAS UTERINAS, NEOVASCULARIZAÇÃO PATOLÓGICA, COLO UTERINO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KFOURI, Cláudio Franco do Amaral et al. Prognostic factors for response to chemotherapy in advanced tumors of the uterine cervix: the role of neoangiogenesis. Revista do Colégio Brasileiro de Cirurgiões, v. 46, n. 1, 2019Tradução . . Disponível em: https://doi.org/10.1590/0100-6991e-20192077. Acesso em: 14 jul. 2025.
APA
Kfouri, C. F. do A., Lombardi, W., Romania, M. C. F. N., Puls, M. L., Ferreira, R. A. M., Lombardi, L. B., & Andrade, J. M. de. (2019). Prognostic factors for response to chemotherapy in advanced tumors of the uterine cervix: the role of neoangiogenesis. Revista do Colégio Brasileiro de Cirurgiões, 46( 1). doi:10.1590/0100-6991e-20192077
NLM
Kfouri CF do A, Lombardi W, Romania MCFN, Puls ML, Ferreira RAM, Lombardi LB, Andrade JM de. Prognostic factors for response to chemotherapy in advanced tumors of the uterine cervix: the role of neoangiogenesis [Internet]. Revista do Colégio Brasileiro de Cirurgiões. 2019 ; 46( 1):[citado 2025 jul. 14 ] Available from: https://doi.org/10.1590/0100-6991e-20192077
Vancouver
Kfouri CF do A, Lombardi W, Romania MCFN, Puls ML, Ferreira RAM, Lombardi LB, Andrade JM de. Prognostic factors for response to chemotherapy in advanced tumors of the uterine cervix: the role of neoangiogenesis [Internet]. Revista do Colégio Brasileiro de Cirurgiões. 2019 ; 46( 1):[citado 2025 jul. 14 ] Available from: https://doi.org/10.1590/0100-6991e-20192077
Artigo de periodico
Mammography coverage and tumor stage in the opportunistic screening context (2019)
Magario, Marcos Benini; Poli Netto, Omero Benedicto ; Tiezzi, Daniel Guimarães ; Carrara, Helio Humberto Angotti ; Andrade, Jurandyr Moreira de ; Reis, Francisco José Candido dos
Source: Clinical Breast Cancer. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, ESTUDOS ECOLÓGICOS, MAMOGRAFIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAGARIO, Marcos Benini et al. Mammography coverage and tumor stage in the opportunistic screening context. Clinical Breast Cancer, v. 19, n. 6, p. 456-459, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.clbc.2019.04.014. Acesso em: 14 jul. 2025.
APA
Magario, M. B., Poli Netto, O. B., Tiezzi, D. G., Carrara, H. H. A., Andrade, J. M. de, & Reis, F. J. C. dos. (2019). Mammography coverage and tumor stage in the opportunistic screening context. Clinical Breast Cancer, 19( 6), 456-459. doi:10.1016/j.clbc.2019.04.014
NLM
Magario MB, Poli Netto OB, Tiezzi DG, Carrara HHA, Andrade JM de, Reis FJC dos. Mammography coverage and tumor stage in the opportunistic screening context [Internet]. Clinical Breast Cancer. 2019 ; 19( 6): 456-459.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1016/j.clbc.2019.04.014
Vancouver
Magario MB, Poli Netto OB, Tiezzi DG, Carrara HHA, Andrade JM de, Reis FJC dos. Mammography coverage and tumor stage in the opportunistic screening context [Internet]. Clinical Breast Cancer. 2019 ; 19( 6): 456-459.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1016/j.clbc.2019.04.014
Artigo de periodico
Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome (2018)
Josahkian, Juliana A.; Saggioro, Fabiano Pinto; Vidotto, Thiago; Ventura, Henrique Torres; Reis, Francisco José Cândido dos; Sousa, Christiâni Bisinoto de; Tiezzi, Daniel Guimarães; Andrade, Jurandyr Moreira de; Koti, Madhuri; Squire, Jeremy Andrew
Source: International Journal of Gynecological Cancer. Unidades: SVOI, FMRP
Subjects: BIOMARCADORES, ESTUDOS DE COORTES, IMUNOHISTOQUÍMICA, NEOPLASIAS OVARIANAS, FATORES DE RISCO, FATORES DE TRANSCRIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOSAHKIAN, Juliana A. et al. Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome. International Journal of Gynecological Cancer, v. 28, n. 3, p. 459-465, 2018Tradução . . Disponível em: https://doi.org/10.1097/igc.0000000000001193. Acesso em: 14 jul. 2025.
APA
Josahkian, J. A., Saggioro, F. P., Vidotto, T., Ventura, H. T., Reis, F. J. C. dos, Sousa, C. B. de, et al. (2018). Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome. International Journal of Gynecological Cancer, 28( 3), 459-465. doi:10.1097/igc.0000000000001193
NLM
Josahkian JA, Saggioro FP, Vidotto T, Ventura HT, Reis FJC dos, Sousa CB de, Tiezzi DG, Andrade JM de, Koti M, Squire JA. Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome [Internet]. International Journal of Gynecological Cancer. 2018 ; 28( 3): 459-465.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1097/igc.0000000000001193
Vancouver
Josahkian JA, Saggioro FP, Vidotto T, Ventura HT, Reis FJC dos, Sousa CB de, Tiezzi DG, Andrade JM de, Koti M, Squire JA. Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome [Internet]. International Journal of Gynecological Cancer. 2018 ; 28( 3): 459-465.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1097/igc.0000000000001193
Artigo de periodico
Identification of a subtype of poorly differentiated invasive ductal carcinoma of the breast based on vimentin and E-cadherin expression (2018)
Orlandini, Leonardo Fleury ; Reis, Francisco José Candido dos ; Silveira, Willian Abraham da; Tiezzi, Marcelo Guimarães; Andrade, Jurandyr Moreira de ; Ribeiro-Silva, Alfredo ; Deaton, Ryan; Bosland, Maarten; Tiezzi, Daniel Guimarães
Source: Revista Brasileira de Ginecologia e Obstetrícia. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, VIMENTINA, EPITÉLIO, MARCADOR MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ORLANDINI, Leonardo Fleury et al. Identification of a subtype of poorly differentiated invasive ductal carcinoma of the breast based on vimentin and E-cadherin expression. Revista Brasileira de Ginecologia e Obstetrícia, v. 40, n. 12, p. 779-786, 2018Tradução . . Disponível em: https://doi.org/10.1055/s-0038-1673700. Acesso em: 14 jul. 2025.
APA
Orlandini, L. F., Reis, F. J. C. dos, Silveira, W. A. da, Tiezzi, M. G., Andrade, J. M. de, Ribeiro-Silva, A., et al. (2018). Identification of a subtype of poorly differentiated invasive ductal carcinoma of the breast based on vimentin and E-cadherin expression. Revista Brasileira de Ginecologia e Obstetrícia, 40( 12), 779-786. doi:10.1055/s-0038-1673700
NLM
Orlandini LF, Reis FJC dos, Silveira WA da, Tiezzi MG, Andrade JM de, Ribeiro-Silva A, Deaton R, Bosland M, Tiezzi DG. Identification of a subtype of poorly differentiated invasive ductal carcinoma of the breast based on vimentin and E-cadherin expression [Internet]. Revista Brasileira de Ginecologia e Obstetrícia. 2018 ; 40( 12): 779-786.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1055/s-0038-1673700
Vancouver
Orlandini LF, Reis FJC dos, Silveira WA da, Tiezzi MG, Andrade JM de, Ribeiro-Silva A, Deaton R, Bosland M, Tiezzi DG. Identification of a subtype of poorly differentiated invasive ductal carcinoma of the breast based on vimentin and E-cadherin expression [Internet]. Revista Brasileira de Ginecologia e Obstetrícia. 2018 ; 40( 12): 779-786.[citado 2025 jul. 14 ] Available from: https://doi.org/10.1055/s-0038-1673700

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration